Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease

Fig. 4

Case example. (A, B) 58-year-old male, KPS of 90%, with the diagnosis of extensive-stage small cell lung cancer and widespread cerebellar leptomeningeal disease on contrast-enhanced magnetic resonance imaging (MRI). He received chemotherapy with carboplatin and etoposide as well as immunotherapy with atezolizumab before and after proton craniospinal irradiation (pCSI) (C) pCSI treatment plan, 30 Gy (RBE) total dose, 10 fractions. (D, E) Three months after pCSI, contrast-enhanced MRI demonstrated complete resolution of LMD

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us